Establishes the prescription drug discount program; establishes that the purpose of the program is to provide access to prescription drugs to participants at a discounted price and to allow for the negotiating of rebates that are exempt from the "best price" rule of the federal social security act; provides for the distribution of rebate funds and repeals a certain provision of the public health law relating thereto.
BILL NUMBER: S121A
TITLE OF BILL : An act to amend the public health law, in relation to creating the prescription drug discount program and to repeal certain provisions of the public health law relating thereto
PURPOSE OR GENERAL IDEA OF BILL : This bill aims to improve the health of New York residents by making prescription drugs more accessible and affordable.
SUMMARY OF SPECIFIC PROVISIONS : Section 1 sets forth legislative findings and purpose. It further declares that the legislature intends to lower enrollment in public health insurance programs by providing more affordable prescription drugs and thus be exempt from the "best price" rule of title XIX of the federal social security act. If further declares that the program shall help reduce the cost of prescription drugs to those lacking prescription drug coverage and those facing gaps in coverage.
Section 2 designates sections 270-277 of the article 2-A of the public health law as Title I and amends it to add a title heading.
Section 3 amends article 2-A of the public health law to add a new Title II that creates the Prescription Drug Discount Card.
Section 280 of the title defines "Contractor," "Covered Drug," "Fiduciary relationship," "Manufacturer," "Participant," "Participating retailer," "Program," and "Rebate agreement."
Section 280-a of the title establishes the program in the department of health for the purpose of providing access to prescription drugs at reduced cost, by deriving state revenue from rebates and applying that revenue to reducing costs for participants. It also directs the commissioner to apply for any necessary waivers to implement the title and allows the commissioner to create regulations if necessary.
Section 280-b describes the procedure through which the board shall contract with administrators to manage the program.
Section 280-c requires the commissioner to negotiate agreements with suppliers in which the suppliers pay rebates to the fiscal administrator of the program for prescription drugs purchased by participants in t.he program. It provides that the commissioner may limit access to drugs covered under the program to those which are extended a rebate by manufacturers.
Section 280-d sets forth the formula used to set the discounted retail prices participants in the program pay for prescription drugs.
Section 280-e outlines the distribution of the rebate funds to the retailers or individual participants, as appropriate.
Section 280-f describes the procedure for participants to register for the program. It directs the commissioner to advise every participant that the program does not apply to any drugs where payment is provided in whole or in part by a third-party payor. Section 280-g requires the department of health to promote the program through education and outreach.
Section 4 of the bill redesignates section 280 of the public health law, as created by section 75 of Part C of a chapter of the laws of 2008, as section 280-h of the public health law. It also creates a new subdivision two in section 280-h that directs the commissioner to enroll anyone who enrolled in the prescription drug discount card under section 280-h of the public health law into the program created by Title II of the public health law and cease enrolling people under section 280-h.
Section 5 provides for the repeal of section 280-h of the public health law.
Section 6 is a severability clause.
Section 7 of the bill establishes effective dates.
JUSTIFICATION : For many people, prescription drugs are necessary for health and life. Increasing prescription drug costs limit their accessibility, especially for seniors, who tend to need them most. These costs also place a burden on health insurance plans and publicly funded medical assistance programs. This bill intends to alleviate those burdens and improve access to necessary medication by organizing the collective market power of New York's prescription drug consumers to negotiate rebates with suppliers.
PRIOR LEGISLATIVE HISTORY : 2006: A.6336-B - passed the Assembly 2007: A.3848 - passed Assembly Committee on Health S.8393 Referred to Health
FISCAL IMPLICATIONS : This bill will have no fiscal impact.
EFFECTIVE DATE : This act shall take effect immediately; except that section 4 of the act shall be deemed to have taken effect on the same day as section 75 of Part C of chapter 58 of the laws of 2008. Section 5 shall take effect 180 days after the act shall become a law.
STATE OF NEW YORK ________________________________________________________________________ 121--A 2009-2010 Regular Sessions IN SENATE (PREFILED) January 7, 2009 ___________Introduced by Sens. SAMPSON, DIAZ, KRUEGER -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- reported favorably from said committee and committed to the Commit- tee on Codes -- reported favorably from said committee and committed to the Committee on Finance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to creating the prescription drug discount program and to repeal certain provisions of the public health law relating thereto THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Legislative findings and declaration. The legislature hereby finds and declares that the high and rising cost of prescription drugs limits access to those of limited means. It makes it more likely that they will become eligible for Medicaid, imposing increased costs on Medicaid. The legislature therefore declares that it is an appropriate public purpose and in the public interest for New York to exercise the powers of the state to provide its residents with means and methods of reducing the high cost of prescription drugs and avoid increased costs to the Medicaid program, and that the prescription drug assistance program created by this act is consistent with these public purposes. The legislature further declares that the purpose of this act is to help reduce the cost of and improve access to prescription drugs, by providing a means to organize and thus maximize the market purchasing power of consumers to earn revenue from supplier rebates and use that revenue to make prescription drugs more affordable. The legislature further declares its intent that the program, as a state prescription drug assistance program and as a program to help avoid increased costs to the Medicaid program, shall be able to negoti-EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD00356-06-9 S. 121--A 2
ate rebates that are exempt from the "best price" rule of title XIX of the federal social security act. S 2. Sections 270 through 277 of article 2-A of the public health law are designated title I and a new title heading is added to read as follows: PREFERRED DRUG AND CLINICAL DRUG REVIEW PROGRAMS S 3. Article 2-A of the public health law is amended by adding a new title II to read as follows: TITLE II PRESCRIPTION DRUG DISCOUNT CARD SECTION 280. DEFINITIONS. 280-A. PRESCRIPTION DRUG DISCOUNT PROGRAM. 280-B. CONTRACTS. 280-C. REBATES. 280-D. RETAIL DISCOUNT PRICES. 280-E. DISTRIBUTION OF REBATE FUNDS. 280-F. REGISTRATION OF PARTICIPANTS. 280-G. EDUCATION AND OUTREACH. S 280. DEFINITIONS. FOR PURPOSES OF THIS TITLE, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS, UNLESS THE CONTEXT REQUIRES OTHER- WISE: 1. "CONTRACTOR" IS ANY PUBLIC, PRIVATE, OR NOT-FOR-PROFIT ENTITY WITH WHICH THE COMMISSIONER CONTRACTS FOR THE PURPOSE OF ADMINISTERING ANY ELEMENT OF THE PROGRAM OR PROVIDING TECHNICAL OR CLINICAL SUPPORT FOR THE PROGRAM. THERE MAY BE ONE OR MORE CONTRACTORS. 2. "COVERED DRUG" MEANS A PRESCRIPTION DRUG THAT IS DESIGNATED BY THE COMMISSIONER TO BE SUBJECT TO PURCHASE BY A PARTICIPANT UNDER THE PROGRAM UNDER SECTION TWO HUNDRED EIGHTY-C OF THIS TITLE. 3. "FIDUCIARY RELATIONSHIP" MEANS A RELATIONSHIP IN WHICH ONE PERSON OR ENTITY IS UNDER A DUTY TO ACT FOR THE BENEFIT OF THE OTHER PERSON OR ENTITY IN THE RELATIONSHIP ON MATTERS WITHIN THE SCOPE OF THE RELATION- SHIP, AND OWES A DUTY OF GOOD FAITH, TRUST, CONFIDENCE, AND CANDOR TO THE OTHER PERSON OR ENTITY. 4. "MANUFACTURER" HAS THE SAME MEANING ASCRIBED TO SUCH TERM IN SECTION NINETEEN HUNDRED TWENTY-SEVEN OF THE FEDERAL SOCIAL SECURITY ACT. 5. "PARTICIPANT" MEANS A NATURAL PERSON WHO MEETS THE ELIGIBILITY GUIDELINES ESTABLISHED IN SECTION TWO HUNDRED EIGHTY-F OF THIS TITLE AND REGISTERS TO PARTICIPATE IN THE PROGRAM. 6. "PARTICIPATING RETAILER" MEANS ANY PERSON OR ENTITY SELLING PRESCRIPTION DRUGS AT RETAIL PRICES THAT IS REGISTERED AS A PARTICIPAT- ING RETAILER IN THE PROGRAM. 7. "PROGRAM" MEANS THE PRESCRIPTION DRUG DISCOUNT PROGRAM ESTABLISHED BY THIS TITLE. 8. "REBATE AGREEMENT" MEANS AN AGREEMENT EXECUTED WITH A MANUFACTURER OR OTHER ENTITY TO PROVIDE REBATES TO THE PROGRAM PURSUANT TO THIS TITLE. S 280-A. PRESCRIPTION DRUG DISCOUNT PROGRAM. 1. THE PRESCRIPTION DRUG DISCOUNT PROGRAM IS HEREBY ESTABLISHED IN THE DEPARTMENT. ITS PURPOSE SHALL BE TO PROVIDE ACCESS TO PRESCRIPTION DRUGS TO PARTICIPANTS AT DISCOUNTED COST, AND TO OBTAIN APPROPRIATE REBATES FROM MANUFACTURERS, AS AUTHORIZED IN THIS TITLE. FOR THE PURPOSES OF MARKETING AND OTHER PURPOSES, THE COMMISSIONER MAY CHOOSE ANOTHER NAME FOR THE PROGRAM; PROVIDED, HOWEVER, THAT ANY SUCH CHANGE OF NAME SHALL NOT AFFECT THE LEGAL DESCRIPTION OR INTENT OF THE PROGRAM, OR ITS EXEMPTION, IF ANY, FROM THE "BEST PRICE" RULE OF TITLE XIX OF THE FEDERAL SOCIAL SECURITYS. 121--A 3
ACT. THE PROGRAM SHALL BE ADMINISTERED IN A MANNER THAT MAXIMIZES SAVINGS FOR THE PARTICIPANTS CONSISTENT WITH THIS TITLE WHILE MINIMIZING ANY COST TO THE STATE, INCLUDING COORDINATING OR COMBINING ADMINIS- TRATION OF ANY ASPECT OF THE PROGRAM WITH MEDICAID OR EPIC TO THE EXTENT CONSISTENT WITH THE INTERESTS OF THOSE PROGRAMS AND THEIR PARTICIPANTS. 2. THE COMMISSIONER MAY REQUIRE EVERY MANUFACTURER PARTICIPATING IN A REBATE AGREEMENT, EVERY PARTICIPANT AND EVERY PARTICIPATING RETAILER TO PROVIDE ANY INFORMATION, AND MAY CONDUCT SUCH AUDITS AND INVESTIGATIONS, AS REASONABLY NECESSARY FOR EFFECTIVE ADMINISTRATION OF THE PROGRAM. ALL INDIVIDUAL IDENTIFYING INFORMATION RELATING TO ANY PATIENT OR CONSUMER ACQUIRED BY THE PROGRAM SHALL BE KEPT CONFIDENTIAL BY THE COMMISSIONER AND SHALL BE USED SOLELY FOR THE PURPOSE OF ADMINISTERING THE PROGRAM. ANY MATTER RELATING TO TRADE OR COMPETITIVE SECRETS OF MANUFACTURERS AND PARTICIPATING RETAILERS, AND ANY MATTER CONCERNING PRICING AND PROFIT, WHICH IS OBTAINED PURSUANT TO THIS SUBDIVISION, OR PURSUANT TO ANY INVESTIGATION OR AUDIT AUTHORIZED PURSUANT TO THIS TITLE, OR OBTAINED INDIRECTLY BY ANY OTHER AUDITS OR INVESTIGATIONS, SHALL BE KEPT CONFI- DENTIAL. 3. IF THE IMPLEMENTATION OF THE PROGRAM REQUIRES ANY FEDERAL APPROVAL OR WAIVER, THE COMMISSIONER SHALL EXPEDITIOUSLY APPLY FOR AND USE HIS OR HER BEST EFFORTS TO OBTAIN SUCH APPROVAL OR WAIVER, CONSISTENT WITH THIS TITLE AND ANY STATE LAW APPLICABLE TO MEDICAID OR EPIC. 4. THE COMMISSIONER MAY MAKE REGULATIONS AND ESTABLISH TERMS AND CONDITIONS CONSISTENT WITH THIS TITLE AND OTHER APPLICABLE LAW, FOR IMPLEMENTATION OF THE PROGRAM. S 280-B. CONTRACTS. 1. THE COMMISSIONER MAY CONTRACT WITH, OR AMEND AN EXISTING CONTRACT WITH, ONE OR MORE PUBLIC, PRIVATE, OR NOT-FOR-PROFIT ENTITIES TO ADMINISTER ANY AND ALL COMPONENTS OF THE PROGRAM OR TO PROVIDE TECHNICAL OR CLINICAL SUPPORT FOR THE PROGRAM. 2. (A) EVERY CONTRACTOR SHALL HAVE A FIDUCIARY RELATIONSHIP WITH AND OBLIGATION TO THE COMMISSIONER AND THE PROGRAM. (B) ALL FUNDS RECEIVED BY ANY CONTRACTOR IN RELATION TO THE PROGRAM SHALL BE RECEIVED BY THE CONTRACTOR SOLELY ON BEHALF OF THE PROGRAM FOR USE OR DISTRIBUTION ONLY PURSUANT TO THIS TITLE, INCLUDING THE CONTRAC- TOR'S CONTRACT WITH THE COMMISSIONER; EXCEPT FOR ANY PAYMENT EXPRESSLY PROVIDED FOR IN THE CONTRACT TO COMPENSATE THE CONTRACTOR FOR ITS SERVICES. THE CONTRACTOR SHALL ACCOUNT TO THE COMMISSIONER FOR ALL FUNDS RECEIVED AND PROCESSED BY THE CONTRACTOR IN RELATION TO THE PROGRAM. THE COMMISSIONER AND THE COMPTROLLER SHALL HAVE ACCESS TO ALL BOOKS AND RECORDS OF THE CONTRACTOR IN RELATION TO THE PROGRAM. (C) THE CONTRACTOR SHALL DISCLOSE TO THE COMMISSIONER AND THE COMP- TROLLER THE TERMS AND CONDITIONS OF ANY CONTRACT OR ARRANGEMENT BETWEEN THE CONTRACTOR AND ANY PARTY RELATING TO THE PROGRAM. S 280-C. REBATES. 1. THE COMMISSIONER SHALL ENTER INTO AGREEMENTS WITH MANUFACTURERS TO ACHIEVE REBATES FROM MANUFACTURERS FOR THEIR DRUG PRODUCTS PURCHASED BY PARTICIPANTS THROUGH THE PROGRAM. 2. THE COMMISSIONER SHALL USE BEST EFFORTS TO MAXIMIZE THE LEVEL OF REBATES OBTAINED FROM MANUFACTURERS TO THE EXTENT ALLOWABLE BY LAW OR REGULATION. THE COMMISSIONER MAY SEEK ANY FEDERAL APPROVAL NEEDED TO ENSURE REBATES RECEIVED UNDER THIS PROGRAM ARE EXCLUDED FROM THE DEFI- NITION OF "BEST PRICE" UNDER SECTION NINETEEN HUNDRED TWENTY-SEVEN OF THE FEDERAL SOCIAL SECURITY ACT. 3. TO ADVANCE THE PURPOSES OF THE PROGRAM, THE COMMISSIONER MAY COOR- DINATE NEGOTIATIONS UNDER THE PROGRAM WITH GOVERNMENTAL AND NON-GOVERN- MENTAL ENTITIES, IN THIS STATE OR ELSEWHERE.S. 121--A 4
4. THE COMMISSIONER SHALL DESIGNATE DRUGS TO BE SUBJECT TO PURCHASE BY PARTICIPANTS UNDER THE PROGRAM. THE COMMISSIONER MAY LIMIT DESIGNATION UNDER THE PROGRAM TO DRUGS COVERED BY A REBATE AGREEMENT. 5. THE COMMISSIONER MAY SEEK SUPPLEMENTAL REBATES FROM MANUFACTURERS CONSISTENT WITH THOSE REBATES PROVIDED TO THE MEDICAID PROGRAM FOR DRUGS ON THE PREFERRED DRUG LIST PURSUANT TO TITLE ONE OF THIS ARTICLE. IN EXCHANGE FOR THE PROVISION OF SUCH REBATES, THE COMMISSIONER MAY DESIG- NATE SUCH DRUGS AS PREFERRED DRUGS IN PROGRAM MARKETING AND EDUCATIONAL ACTIVITIES AND MATERIALS. THE COMMISSIONER IS AUTHORIZED TO LIMIT PROGRAM COVERAGE OF DRUGS IN THERAPEUTIC CLASSES INCLUDED IN THE PREFERRED DRUG PROGRAM TO THOSE ON THE PREFERRED DRUG LIST. S 280-D. RETAIL DISCOUNT PRICES. 1. A PERSON OR ENTITY MAY BECOME A PARTICIPATING RETAILER BY AGREEING TO THE TERMS AND CONDITIONS OF PROGRAM PARTICIPATION, AND MEETING QUALIFICATIONS, AS ESTABLISHED BY THE COMMISSIONER. THE COMMISSIONER MAY REQUIRE PERIODIC RE-REGISTRATION. 2. A PARTICIPATING RETAILER MAY NOT CHARGE A PARTICIPANT A PRICE FOR A COVERED DRUG WHICH IS HIGHER THAN THE AMOUNT PAID BY THE MEDICAID PROGRAM PURSUANT TO SECTION THREE HUNDRED SIXTY-SEVEN-A OF THE SOCIAL SERVICES LAW, LESS THE APPLICABLE REBATE AMOUNT ADVANCED BY THE PROGRAM IN ACCORDANCE WITH SECTION TWO HUNDRED EIGHTY-E OF THIS TITLE. S 280-E. DISTRIBUTION OF REBATE FUNDS. 1. THE APPROPRIATE CONTRACTOR SHALL EXPEDITIOUSLY MAKE PAYMENTS TO PARTICIPATING RETAILERS FOR THE ESTIMATED REBATE AMOUNTS, RELATING TO COVERED DRUGS DISPENSED BY PARTIC- IPATING RETAILERS TO PROGRAM PARTICIPANTS, SUBJECT TO SUBSEQUENT RECON- CILIATION AGAINST ACTUAL REBATES COLLECTED FROM MANUFACTURERS. RECONCIL- IATION SHALL NOT REQUIRE RECOUPMENT FROM OR PAYMENTS TO PARTICIPANTS OR PARTICIPATING RETAILERS FOR PREVIOUS PURCHASES UNDER THE PROGRAM, BUT MAY INCLUDE, AS APPROPRIATE, PROVISION FOR ADJUSTMENT AGAINST ESTIMATED REBATE AMOUNTS FACTORED INTO FUTURE PRICES TO BE PAID BY PARTICIPANTS. 2. THE COMMISSIONER MAY MAKE ARRANGEMENTS WITH MANUFACTURERS CONCERN- ING THE TIMING OR STRUCTURE OF THE REBATE PAYMENTS AS IN HIS OR HER DETERMINATION SHALL BEST FACILITATE LOWER PRICES FOR PARTICIPANTS, EXPE- DITIOUS PAYMENT OF REBATES AND EFFICIENT ADMINISTRATION OF THE PROGRAM. S 280-F. REGISTRATION OF PARTICIPANTS. 1. TO BE ELIGIBLE TO BE A PARTICIPANT, A PERSON SHALL BE A RESIDENT OF NEW YORK, REGARDLESS OF AGE, WHO HAS A HOUSEHOLD INCOME EQUAL TO OR LESS THAN THE GREATER OF (A) THREE HUNDRED FIFTY PERCENT OF THE FEDERAL POVERTY LEVEL FOR A HOUSEHOLD OF THAT SIZE (AS DEFINED AND UPDATED BY THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES); OR (B) THE INCOME ELIGIBILITY LEVELS ESTAB- LISHED UNDER SUBDIVISION ONE OR TWO OF SECTION TWO HUNDRED FORTY-TWO OF THE ELDER LAW, IS NOT IN RECEIPT OF MEDICAID, AND MEETS SUCH OTHER REQUIREMENTS AS THE COMMISSIONER MAY ESTABLISH CONSISTENT WITH THIS TITLE. ANY PERSON ENROLLED IN THE PRESCRIPTION DRUG DISCOUNT PROGRAM UNDER SECTION TWO HUNDRED EIGHTY-H OF THIS TITLE SHALL BE ELIGIBLE TO BE A PARTICIPANT UNDER THIS PROGRAM. 2. ANY PERSON ELIGIBLE TO BE A PARTICIPANT MAY BECOME A PARTICIPANT IN THE PROGRAM BY REGISTERING WITH THE PROGRAM. ANY PERSON ENROLLED IN THE PRESCRIPTION DRUG DISCOUNT PROGRAM UNDER SECTION TWO HUNDRED EIGHTY-H OF THIS TITLE SHALL AUTOMATICALLY BE REGISTERED BY THE COMMISSIONER IN THIS PROGRAM. 3. THE COMMISSIONER SHALL ADVISE EACH APPLICANT THAT THE PROGRAM DOES NOT APPLY TO ANY PRESCRIPTION DRUG PURCHASE FOR WHICH REIMBURSEMENT (IN WHOLE OR IN PART) IS PROVIDED BY ANY THIRD-PARTY PAYER. THE COMMISSIONER MAY REQUIRE PERIODIC RE-REGISTRATION AND MAY REQUIRE THE PARTICIPANT TO INFORM THE PROGRAM OF ANY CHANGE IN THE INFORMATION PROVIDED. THE COMMISSIONER SHALL MAKE THE APPLICATION PROCESS AS SIMPLE AS REASONABLYS. 121--A 5
POSSIBLE TO MAXIMIZE PARTICIPATION IN THE PROGRAM CONSISTENT WITH PROPER ADMINISTRATION OF THIS TITLE. 4. THE COMMISSIONER SHALL REVIEW ALL APPLICATIONS TO DETERMINE IF THE APPLICANT APPEARS TO MEET THE ELIGIBILITY REQUIREMENTS FOR THE FAMILY HEALTH PLUS PROGRAM UNDER SECTION THREE HUNDRED SIXTY-NINE-EE OF THE SOCIAL SERVICES LAW, THE CHILD HEALTH INSURANCE PROGRAM UNDER SECTION TWENTY-FIVE HUNDRED TEN AND TWENTY-FIVE HUNDRED ELEVEN OF THIS CHAPTER, OR MEDICAL ASSISTANCE UNDER ARTICLE FIVE OF THE SOCIAL SERVICES LAW. IF THE APPLICANT DOES APPEAR TO MEET ELIGIBILITY REQUIREMENTS FOR ANY OF THOSE PROGRAMS, THE COMMISSIONER SHALL, IN ADDITION TO ANY OTHER ACTIONS TAKEN UNDER THIS TITLE, PROVIDE THE APPLICANT WITH INFORMATION AND ENROLLMENT MATERIAL ABOUT SUCH OTHER PROGRAM. HOWEVER, THE COMMISSIONER SHALL REGISTER THE APPLICANT UNDER THIS SECTION IF THE APPLICANT IS OTHERWISE ELIGIBLE. S 280-G. EDUCATION AND OUTREACH. THE COMMISSIONER SHALL CONDUCT EDUCA- TION AND OUTREACH TO PROMOTE THE PROGRAM AND TO ENCOURAGE ELIGIBLE PERSONS AND ENTITIES TO BECOME PARTICIPANTS AND PARTICIPATING RETAILERS. S 4. Section 280 of the public health law, as added by section 75 of part C of chapter 58 of the laws of 2008, is renumbered section 280-h, and amended to read as follows: S 280-h. Prescription drug discount program. 1. The prescription drug discount program is hereby established in the department. The drug discount card shall be available to any resident between the ages of fifty and sixty-four, and any resident of any age who has been deter- mined to meet the disability criteria in 20 C.F.R. S 404.1505, who: meets the income eligibility levels established under subdivision one or two of section two hundred forty-two of the elder law; is not in receipt of medical assistance under title eleven of article five of the social services law. The drug discount card shall offer discounts on drug purchases which are not covered by other public or private third party payment sources. Provided, however, that participation by a provider pharmacy and drug manufacturers shall be voluntary and reimbursement to the provider pharmacy under the drug discount card program shall be adjudicated and paid within two business days for any rebates, dispens- ing fees and drug costs not paid by the resident eligible for such program at the point of sale. 2. THE COMMISSIONER SHALL, AS EXPEDITIOUSLY AS POSSIBLE, INTEGRATE THE OPERATION OF THE PRESCRIPTION DRUG DISCOUNT PROGRAM UNDER THIS SECTION WITH THE PRESCRIPTION DRUG DISCOUNT PROGRAM UNDER SECTION TWO HUNDRED EIGHTY-A OF THIS TITLE. WHEN THE COMMISSIONER BEGINS REGISTERING PARTIC- IPANTS UNDER SECTION TWO HUNDRED EIGHTY-A OF THIS TITLE, HE OR SHE SHALL CEASE ENROLLING PARTICIPANTS UNDER THIS SECTION. ANY PERSON ENROLLED IN THE PROGRAM UNDER THIS SECTION SHALL BE AUTOMATICALLY REGISTERED BY THE COMMISSIONER IN THE PROGRAM UNDER SECTION TWO HUNDRED EIGHTY-A OF THIS TITLE. S 5. Section 280-h of the public health law, as amended by section four of this act, is REPEALED. S 6. Severability. If any provision of this act, or any application of any provision of this act, is held to be invalid, or ruled by any federal agency to violate or be inconsistent with any applicable federal law or regulation, that shall not affect the validity or effectiveness of any other provision of this act, or of any other application of any provision of this act. S 7. This act shall take effect immediately; provided, however that:S. 121--A 6
(a) the amendments to article 2-A of the public health law made by sections two and four of this act shall not affect the repeal of such article and shall be deemed repealed therewith; (b) section five of this act shall take effect on the one hundred eightieth day after this act shall have become a law; (c) any rebate payment due from any drug manufacturer and any reimbursement due under section 280-h of the public health law shall be paid notwithstanding the repeal of section 280-h made by section five of this act; and (d) the amendments to article 2-A of the public health law made by section three of this act shall survive the expiration and repeal of such article as provided in section 79 of part C of chapter 58 of the laws of 2005, as amended.